Clinical Significance of the Costimulatory Molecule B7-H1 in Barrett Carcinoma

Our data suggest that B7-H1 may represent a new prognostic marker for patients with Barrett carcinoma. Furthermore, given its immune-inhibitory function, B7-H1 may represent a potential target in the treatment of Barrett carcinoma.